ezCaretech Valuation Multiples

Discover revenue and EBITDA valuation multiples for ezCaretech and similar public comparables like PharmX Technologies, SMAIO, MeVis, Mach7 Technologies and more.

ezCaretech Overview

About ezCaretech

ezCaretech Co Ltd is a medical IT company. It specializes in medical information business in domestic medium and large hospitals as well as exporting hospital information system to foreign countries. It offers medical IT solution that computerize all the processes of hospital work change to hospital that boasts outstanding medical services.


Founded

2001

HQ

South Korea

Employees

N/A

Financials (FY)

Revenue: $53M
EBITDA: $5M

EV

$54M

Valuation Multiples

Start free trial

Valuation Multiples for 15K+ Public Comps

AdidasAirbnbAmazonCiscoCoca-ColaDellDropboxIBMIntelMcDonaldsNikeNVIDIASamsungSpotifyTeslaToyota
Browse Valuation Multiples

ezCaretech Financials

ezCaretech reported last fiscal year revenue of $53M and EBITDA of $5M.

In the same fiscal year, ezCaretech generated $13M in gross profit, $5M in EBITDA, and $4M in net income.


ezCaretech P&L

In the most recent fiscal year, ezCaretech reported revenue of $53M and EBITDA of $5M.

ezCaretech is profitable as of last fiscal year, with gross margin of 24%, EBITDA margin of 10%, and net margin of 8%.

See analyst estimates for ezCaretech
Last FY202320242025202620272028
Revenue$53M$47M$48M$52M
Gross Profit$13M$8M$10M$12M
Gross Margin24%17%21%24%
EBITDA$5M$650K$3M$5M
EBITDA Margin10%1%6%9%
EBIT Margin6%(1%)2%6%
Net Profit$4M($1M)$1M$3M
Net Margin8%(2%)3%7%

Financial data powered by Morningstar, Inc.

ezCaretech Stock Performance

ezCaretech has current market cap of $56M, and enterprise value of $54M.

Market Cap Evolution


ezCaretech's stock price is $4.07.

ezCaretech share price decreased by 1.0% in the last 30 days, and by 32.5% in the last year.

ezCaretech has an EPS (earnings per share) of $0.30.

See more trading valuation data for ezCaretech
EVMarket CapPrice 1DPrice 1MPrice 3MPrice 12MEPS
$54M$56M0.5%-1.0%-30.3%-32.5%$0.30

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.

Start Free Trial

ezCaretech Valuation Multiples

ezCaretech trades at 1.0x EV/Revenue multiple, and 10.4x EV/EBITDA.

See NTM and 2027E valuation multiples for ezCaretech

ezCaretech Financial Valuation Multiples

As of July 18, 2026, ezCaretech has market cap of $56M and EV of $54M.

ezCaretech has a P/E ratio of 13.6x.

Last FY202320242025202620272028
EV/Revenue1.0x1.2x1.1x1.0x
EV/EBITDA10.4x83.4x19.2x11.7x
EV/EBIT16.0x(94.4x)46.9x18.7x
EV/Gross Profit4.2x7.0x5.4x4.4x
P/E13.6x(55.4x)40.8x16.1x
EV/FCF(23.3x)30.4x8.9xn/m

Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Verified ezCaretech Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.

FactSetMorningstar
Start Free Trial

ezCaretech Margins & Growth Rates

In the most recent fiscal year, ezCaretech reported gross margin of 24%, EBITDA margin of 10%, and net margin of 8%.

See estimated margins and future growth rates for ezCaretech

ezCaretech Margins

Last FY202420252026202720282029
Gross Margin24%21%24%24%
EBITDA Margin10%6%9%10%
EBIT Margin6%2%6%6%
Net Margin8%3%7%8%
FCF Margin(4%)13%0%(4%)

ezCaretech Growth Rates

23/2424/2525/2626/2727/2828/29
Revenue Growth3%8%2%
Gross Profit Growth29%23%4%
EBITDA Growth335%64%12%
EBIT Growth(301%)151%16%
Net Profit Growth(236%)154%18%
FCF Growth240%(99%)(6225%)

Data powered by FactSet, Inc. and Morningstar, Inc.

ezCaretech Operational KPIs

ezCaretech's Rule of 40 is 12% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).

ezCaretech's Rule of X is 15% (created by Bessemer, Rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).

Access forward-looking KPIs for ezCaretech
Last FY202320242025202620272028
Rule of 4012%---
Bessemer Rule of X15%---
S&M Expenses to Revenue3%2%2%2%
G&A Expenses to Revenue1%1%1%1%
R&D Expenses to Revenue3%1%1%3%
Opex to Revenue18%18%18%18%

Data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 230+ Verticals

ezCaretech Competitors

ezCaretech competitors include PharmX Technologies, SMAIO, MeVis, Mach7 Technologies, Singular Health, SOFTMAX, Data Horizon, Forian, Rocket Doctor AI and DocCheck.

Most ezCaretech public comparables operate across Healthcare Software, EHR & Practice Management, B2B SaaS, Vertical SaaS and HealthTech.

EV/RevenueEV/EBITDA
Last FYLTM2027ELast FYLTM2027E
PharmX Technologies9.9x-52.1x-
SMAIO5.3x4.6x(56.6x)(68.0x)
MeVis2.5x-11.8x-
Mach7 Technologies2.3x1.9x(32.7x)(14.4x)
Singular Health293.6x-(9.7x)-
SOFTMAX1.1x1.1x9.2x-
Data Horizon2.3x-16.5x-
Forian----

This data is available for Pro users. Sign up to see all ezCaretech competitors and their valuation data.

Start Free Trial

ezCaretech VC Funding History

Before going public, ezCaretech raised $34M in total equity funding, across 2 rounds.


ezCaretech Funding Rounds

DateStageInvestorsRaisedValuationRev. MultipleDeal Summary
Jan-23Series AKakao Healthcare$8M-ezCaretech Co., LTD, a leading South Korean provider of healthcare information management systems, develops the BESTCare platform, an integrated suite covering clinical and administrative IT needs for large hospitals. The company announced a funding round of KRW 9.9 billion from Kakao Healthcare on January 18, 2023. This investment supports ezCaretech's position in the domestic healthcare IT market alongside competitors like Samsung SDS and LG CNS. Kakao Healthcare, a subsidiary of Kakao focused on building a digital healthcare ecosystem, led the investment as part of its new initiatives in healthcare data aggregation and digital transformation. ezCaretech's BESTCare solution is widely used in tertiary hospitals, emphasizing deep integration to reduce system management complexities and reinforce customer switching costs. The company invests 10-15% of sales in R&D to maintain competitiveness, including development of BESTCare 2.0, a cloud-based platform, and pursues international expansion in the Middle East and North America.
Aug-21Undisclosed stageNaver Labs$26M--

Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples

Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.

Start Free Trial

About ezCaretech

When was ezCaretech founded?ezCaretech was founded in 2001.
Where is ezCaretech headquartered?ezCaretech is headquartered in South Korea.
Is ezCaretech publicly listed?Yes, ezCaretech is a public company listed on Korea Exchange.
What is the stock symbol of ezCaretech?ezCaretech trades under 099750 ticker.
When did ezCaretech go public?ezCaretech went public in 2019.
Who are competitors of ezCaretech?ezCaretech main competitors include PharmX Technologies, SMAIO, MeVis, Mach7 Technologies, Singular Health, SOFTMAX, Data Horizon, Forian, Rocket Doctor AI, DocCheck.
What is the current market cap of ezCaretech?ezCaretech's current market cap is $56M.
What is the current revenue of ezCaretech?ezCaretech's last fiscal year revenue is $53M.
What is the current EV/Revenue multiple of ezCaretech?Current revenue multiple of ezCaretech is 1.0x.
Is ezCaretech profitable?No, ezCaretech is not profitable.
How many companies ezCaretech has acquired to date?ezCaretech hasn't acquired any companies yet (or none have been disclosed publicly).
In how many companies ezCaretech has invested to date?ezCaretech hasn't invested in any companies yet (or none have been disclosed publicly).

See public comps similar to ezCaretech

Lists including ezCaretech

Start Your
Free Trial Today

Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.

Start Trial